Skip to content

Central sensitisation in patients with chronic low back pain radiating to the leg

Central sensitisation in patients with chronic low back pain radiating to the leg - CLaSSICO

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50666
Enrollment
100
Registered
2017-11-20
Start date
2018-06-05
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic low back pain radiating to the leg Chronic lumbosacral radicular syndrome

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Presence of chronic low back pain (> 3 months) with radiation to the leg Leg pain > back pain Physician must consider a minimum of 1 dSNRB, tSNRB or pRF as an appropriate treatment intervention; Written informed consent Age: 18 years or older

Exclusion criteria

Exclusion criteria: Exclusion criteria for segmental nerve blocks (see our local protocols - appendix 2) No or not sufficient understanding of Dutch language Incapacity to follow instructions Mental incompetence to provide informed consent Pain in one (or more) sites where BSE and QST will be applied (except for the most painful point in the painful dermatome).

Design outcomes

Primary

MeasureTime frame
* QST (Quantitative Sensory Testing) * BSE (Bed Side Examination) * CSI (Central Sensitization Inventory)

Secondary

MeasureTime frame
Other measurements (mostly part of the standardised care or CaU) are: Pain Catastrophising Scale (PCS), Pain Vigilance and Awareness Questionnaire (PVAQ), 36-Item Short Form Health Survey (SF-36), Pain Disability Index (PDI), Work Ability Index (WAI), STarT Back Screening Tool (SBST), Numeric Rating Scale for Pain (NRS) and drawing in standard leg images Other study parameters Demographic descriptive items: age, gender, weight, height, co-morbidities, medication and ethnic background.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)